| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/15/2001 | CN1308056A Heterocyclic benzonitrile |
| 08/14/2001 | US6274734 Process for making pyrimidine derivatives |
| 08/14/2001 | US6274729 Prevent tissue damage |
| 08/14/2001 | US6274728 Esterified dye |
| 08/14/2001 | US6274587 Tricyclic dihydropyrimidine potassium channel openers |
| 08/14/2001 | US6274086 Matrix comprising arrays of excitation light-transmitting optical fibers and phosphorescence-detecting/transmitting optical fibers whereby pulses of light are sequentially emitted and phosphorescence detected at a plurality of sites |
| 08/14/2001 | US6274065 Composition comprising polymer matrix or precursor, host chromophore, pigment precursor, wherein absorption spectrum of pigment (guest chromophore), obtained from precursor, overlaps with fluorescence emission spectrum of host chromphore |
| 08/14/2001 | CA2148380C 5-arylindole derivatives |
| 08/14/2001 | CA2029265C 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001056555A2 Use of cox-2 inhibitors for the treatment of constipation |
| 08/09/2001 | WO2001023392A8 Tetracyclic benzimidazole derivatives and combinatorial libraries thereof |
| 08/09/2001 | WO2001019788A3 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2001018004A3 PYRAZOLO[4,3-d]PYRIMIDINES |
| 08/09/2001 | WO2000075144A8 Peroxynitrite decomposition catalysts and methods of use thereof |
| 08/09/2001 | US20010012891 Pyrrolo(2,3-c)azepin-8-one |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/08/2001 | EP1122257A1 Benzimidazole compounds as ORL1-receptor agonists |
| 08/08/2001 | EP1121409A1 Detergent compositions or components |
| 08/08/2001 | EP1121363A2 6-SUBSTITUTED PYRAZOLO 3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 08/08/2001 | EP1121362A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 08/08/2001 | EP1121361A1 Pyrazolo-triazine derivatives as ligands for gaba receptors |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP0625155B1 Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors |
| 08/08/2001 | CN1307581A Method for producing anellated triazoles and new anellated trizoles and their use |
| 08/08/2001 | CN1307579A Substituted triazolo-pyridazing derivative, pharmaceutical composition made therefrom |
| 08/08/2001 | CN1069321C New inhibitors of platelet aggregation |
| 08/08/2001 | CN1069319C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271251 Cardiovascular disorders |
| 08/07/2001 | US6271229 Method of treating gastrointestinal motility disorders |
| 08/07/2001 | US6271228 Blood pressure stabilization during hemodialysis |
| 08/02/2001 | WO2001055151A1 Polymeric micellar structure |
| 08/02/2001 | WO2001055149A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 08/02/2001 | WO2001055148A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | WO2001055131A2 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055110A1 Isatine derivatives with neurotrophic activity |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | DE10004157A1 New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis |
| 08/02/2001 | DE10003323A1 Neue Imidazo[1,3,5[triazinone und ihre Verwendung New imidazo [1,3,5 [triazinones and their use |
| 08/02/2001 | DE10003296A1 Neue Triazolotriazinone und ihre Verwendung New Triazolotriazinone and their use |
| 08/02/2001 | CA2398173A1 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
| 08/02/2001 | CA2394525A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | CA2394292A1 Isatine derivatives with neurotrophic activity |
| 08/02/2001 | CA2297706A1 Anticonvulsive and antiallergic/anti-asthmatic pyrazolo-(3,4-d)pyrimidines having affinity for the adenosine receptor, and process for their preparation |
| 08/01/2001 | EP1120418A1 Fused pyridazine compounds, process for the preparation of the same and uses thereof |
| 08/01/2001 | EP1120414A1 Disubstituted maleimide compounds and medicinal utilization thereof |
| 08/01/2001 | EP1120119A1 Remedies for photochemotherapy |
| 08/01/2001 | EP1119568A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/01/2001 | EP0941228B1 PROCESS FOR PREPARING MeO-Peg-PROTECTED DIHYDROQUININE OR DIHYDROQUINIDINE DERIVATIVES, DIHYDROQUININE OR DIHYDROQUINIDINE DERIVATIVES AND THEIR USE |
| 08/01/2001 | EP0719268B1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY |
| 08/01/2001 | EP0691846B1 Imidazolo-quinoxalinones for treating diseases of the central nervous system |
| 08/01/2001 | CN1306539A Octahydro-6,10-dioxo-6h-pyridazino/1,2-a//1,2/diazepin-1-carboxylic acid derivatives, prepn. method and use for preparing therapeutically active compounds |
| 07/31/2001 | US6268510 Rearrangement process and tricyclic and tetracyclic compounds |
| 07/31/2001 | US6268496 Certain imidazoquinoxalines: a new class of GABA brain receptor ligands |
| 07/31/2001 | US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases |
| 07/31/2001 | US6268360 Urination delay |
| 07/26/2001 | WO2001053300A1 Porphyrins and related compounds |
| 07/26/2001 | WO2001053274A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | US20010009962 One pot process for preparing sildenafil (drug for erectile dysfunction) and derivatives by reacting for example 4-(2-methoxy-5-(4-methyl-1-piperazinylsulfonyl)benzamido)-1-methyl-3-propyl -1H-pyrazole-5-carboxamide with ethanol |
| 07/26/2001 | CA2399217A1 Porphyrins and related compounds |
| 07/26/2001 | CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2394703A1 Amide compounds for inhibiting protein kinases |
| 07/25/2001 | EP1118612A1 Piperazine derivatives possesing nootropic activity |
| 07/25/2001 | EP1118322A1 Drugs for improving vesical excretory strength |
| 07/25/2001 | EP1117666A2 Process for the preparation of corroles and several such new compounds, including chiral derivatives, and the use thereof |
| 07/25/2001 | EP1117665A1 Photosensitizers for photodynamic applications |
| 07/25/2001 | EP1117659A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP0877745B1 N-( 1,2,4] triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
| 07/25/2001 | EP0820997B1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES |
| 07/25/2001 | EP0783501B9 pyrimidone derivatives with antifungal activity |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305481A Piperazino derivatives as neurokinin antafonists |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/24/2001 | US6265536 Cyclic hexapeptides having antibiotic activity |
| 07/24/2001 | US6265419 Irritable bowel disorder |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | CA2240594C 2,7-substituted octahydro-pyrrolo¬1,2-a|pyrazine derivatives |
| 07/19/2001 | WO2001051572A2 Novel colorants, colorant stabilizers, ink compositions, and improved methods of making the same |
| 07/19/2001 | WO2001051492A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | WO2001051491A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 07/19/2001 | WO2001051042A2 Treatment of diabetic ulcers |
| 07/19/2001 | WO2001005794A3 Method for making debromohymenialdisine and analogs thereof |
| 07/19/2001 | WO2000076970A3 Serine protease inhibitors |
| 07/19/2001 | WO2000053580A3 N-protected synthesis method for use in making porphyrins |
| 07/19/2001 | US20010008879 Comprising organotin(IV), organogermanium(IV), organopaltinum(IV), organopalladium(IV), organolead(IV) or organophosphorous(III) phthalocyanine and napthalocyanines having Q-band absorption maxima at greater than 660 nm |